Dear Members,
A circular from the Editors-In-Chief of Alzheimer’s Research & Therapy, a new Medical Journal to be launched soon which may of interest to our medical professionals, counsellors and the public.
An invitation to submit to Alzheimer's Research & Therapy
Editors-in-Chief:
Doug Galasko, University of California, San Diego
Todd Golde, Mayo Clinic, Florida
Gordon Wilcock, University of Oxford
Dear Colleague,
We are writing to let you know about Alzheimer's Research & Therapy, a brand new journal soon to be launched by BioMed Central.
Alzheimer's Research & Therapy is a peer-reviewed journal that aims to be the major forum for translational research into Alzheimer's disease. The journal will publish basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies.
Although the journal's primary focus is Alzheimer's dementia, the scope will encompass other neurodegenerative diseases. Review articles and expert commentary will accompany key papers.
The journal is led by three Editors-in-Chief and is supported by a renowned international Editorial Board.
We invite you to submit your next outstanding research manuscript to Alzheimer's Research & Therapy. The journal offers rapid, high-quality peer review, and immediate publication on acceptance.
All research published in Alzheimer's Research & Therapy will be open access - freely available to all with the copyright retained by the authors. The published version of your article will immediately be placed in PubMed and PubMed Central, ensuring the high visibility of your research. This complies with the NIH Public Access Policy and the Wellcome Trust Open Access Policy.
The journal has unrestricted space, allowing authors to submit unlimited numbers of figures, tables and supplementary material, all at no extra cost to the standard article processing charge. To find out whether your article or concept for a review article is suitable for the journal, you can send a pre-submission enquiry to editorial@alzres.com.
Please submit your manuscript via our online submission system. For more information about the journal, contact editorial@alzres.com or visit our instructions for authors.
If you would like to keep abreast of news about Alzheimer's Research & Therapy and to receive a copy of the print preview of our inaugural issue simply register your email address on the website:
http://www.alzres.com/info/update.
Kind regards,
Doug Galasko, Todd Golde and Gordon Wilcock
Editors-in-Chief, Alzheimer's Research & Therapy
No comments:
Post a Comment